Enfermedades gastrointestinales y hepáticas

Foto de Enfermedades gastrointestinales y hepáticas

Foto de King's College Hospital NHS Foundation Trust

King's College Hospital NHS Foundation Trust

Londres, Reino Unido

King's College Hospital NHS Foundation Trust-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2019

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170

2015

Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe
HIV Medicine, Vol. 16, Núm. 9, pp. 544-552